湖南方盛制药股份有限公司关于控股股东部分股份质押的公告

Core Viewpoint - The announcement details the pledge of shares by the controlling shareholder of Hunan Fangsheng Pharmaceutical Co., Ltd., Zhang Qinghua, indicating a controlled risk level associated with the pledged shares [2][3]. Group 1: Share Pledge Details - Zhang Qinghua has completed the pledge of 8.75 million shares, representing 1.99% of the company's total share capital [2]. - As of the announcement date, Zhang Qinghua directly holds 156,019,500 shares, which is 35.53% of the total shares (439,081,360 shares) [2]. - The total number of pledged shares by Zhang Qinghua is 64,075,200, accounting for 41.07% of his directly held shares and 14.59% of the company's total shares [2]. Group 2: Pledge Risk Assessment - The total pledged shares by Zhang Qinghua and his concerted parties amount to 64,075,200, which is 38.70% of their total holdings, and the pledge ratio does not exceed 80%, indicating manageable risk [2][6]. - Zhang Qinghua's personal credit status is good, and he is planning for the upcoming maturity of pledged shares, with no substantial default risk anticipated [6]. Group 3: Impact on Company Operations - The pledged shares are primarily for replacing other maturing financing, and this action will not significantly impact the company's main business, financing costs, or operational sustainability [6]. - The pledge will not adversely affect the company's governance or daily management, nor will it lead to a change in actual control of the company [6].